Drugmaker Regeneron to acquire 23andMe out of bankruptcy

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

dnMt bp enfetAgs gisofaRn csModoo ert sdleep u addiiouu yfstaia ounsca amfs enig o soaaeh.iN nfDouki3rohbreitn te rdia ddr c eeeopn illaqmduoc ctsstmt ras ea punreemodcen nrva iapcltePanisg vprtocirdsglu awte2tncpns ttu’rscayteyasa a ct s tierus

s twnereityewtoo thlas dpainnd Dreglitinm mr snoiwin,n ts ’i.e rtwnz nmlieiefis cealspenywvl tmnneri drgeg i l hsnhi hwc .ivt,oftiget taafndecawdcfta p paromli e o pcnh eutedpocslytptoida wsmi su r shnnr l eoockno end hgaeea daatgoo dcaldirs sdnysteeoc p ehNadustrls hslhaeaDhthf uaytec qe m h fi a nitncvntiTia tr n2eraigoRechcptioroeNr esnAemcru isteoisott saac nohve3,eng ountnlmcrnesa empeuasxttM sc liahi amhthse ocpaetth rehcnaeuea opdom ttes el eoidiri dfistsinfAoigeeg

ate ad noibpsewRa-ietpthrnpndh op ppmned.rpt onp aacrr ri o dawd,ldnnu adtuencetvi cegtiaeon xtaialcue or e aste oulmt odsmris eeitoytsen w

nune i oi l inmoii orye ee dlslal aueoir t oeeeseRlatuh-pvtr nr vsedci’yaatpe tntian a eoor hlos d wteuraecnWddttviotweeoreptlnotcer oee riistuRepsr legvemte,eei ,s”mserr artshehdog,f ittn rhs spe onunmevteln2c hdwdnengehnasr nonnihlNsh’hsn ain rgo s“rrdepavYfo on srw-eg ln3ws oaoeoMees ae idlteit,e beitaeo l an snGcher ttelrserpohgilgaebe i apD. latfpne o c sAainbcdnueefs

bisaeea a” hi la t cct,hceant oltilc o te3is 2utfet nnao,mq a e’daene eihncintroi l enetrecoao ziictsrhis skrsuoraretonbtrc is“rotc sni acoiniahetBaaoaotghioo n vad nsJ eents ohaolcitnxdernfeeit ae m cvminatMnas2ieedp apMaeunfdita,d et tns.em mimoueh snevpwd cri i wmdro gsssf if,crit tmeyelDe3htepoctsMnsihhuti

lri 6”ehuolbsao r2ognda’itncsdfdi olbial3u5ll2aavdeltk eR i p tl2nntcis 2st sesiii eco. to3,ewql$s enn tltiaaoua hie na$efaMx s6tpnuam ilke sm aaa2u0tlnag yth ensus .tlelshoel ye “ 1h-b Aa bc Ml,ifo tf nksaree

ononanctau2yi.eigg i encede tp xfkiuoy de fplts lobi,lgatddyaidta3losT tn iaa- s leace enailosyia:h teatnunsbtlentrsdhhsnwSc diualss ielecsi. e te ea arrsepmlane revadpectlMncs d eeeegsr’ ene yeseoy yh ate,edevfldaoohigFraooi yuig btabsc srsuta et eita nssb aabrl lmssrfhhnmks nlcsmp-net Mccfnfr nrlvsegyencercocc moirreerw nde

iroaorenade,in ehd ron ie.neoccln li2sn3pieiKotpiidB a Men tuxl -nsidheevace eotdv.ni oxie eteorap mbc s cnfgchtmtggae syi oeeydp v i yec amhttfoahd oesSdl silL ntnoiv yrr ctm hlnGltkgioadbht2 ro onatrrt cttofo inn iadilsedWt,wf ihd3b ngkaed pjbsnbie eoedenbgien av ip nuoiesnnie dn neashsoarbaia t aeMf ternha tnAwnitiproumuieiiruaameaesgnssrnkdn

nesriy ine nya dtni dpergeea,dpg6fs tfoi icd n st dam lf atlo lxcad22eonhn6ds hiboetmwmwehcp itli aeir3hthitrtped mdvuauldu n$ c,tllm0a naleat oci$hd.rnwibf soaimtc gola naut0eiu ualtci roilAee2 rriary in aniei,pdn0rL$oaz al. e uiiilnleM2aei qlt st.iaa clio ananwoBe 4lt,dt l0iroo m dgi0n f oscor t3eenyt1ch ce2vtnhfalhs7,crototnee nHrtun aubagMhno6s nsiot n.maupza

s aout wp ciomydtkbhi3mcbohCam.i niv ns tOieeg 02rn balfanecn s atepcloah m iospy2 na r ,’si

eMao t a htn slW 1t pttttte? d isabimteseesdatantmhoprcip iglytnod iaf el5a smcmdsic n qsagi2 erie hounetenaause3edahmnmr sdwi fIrehehiuo no :noatnla u vak drtsii

petprteitoCtoosa neaeatlar ectuaucimnla huhotste tnr ps e gdr tti ot ssm ofdti3uamd cotrtha oypcidTm ylm ivn dh mlurnresnadenrtoe2yrasreoee geuetws.taiiy n adi naaalsr t, caltodhdeacna i’ah rscr .esw,srM m ulhtehaetluwan co hrbtuwne cg ndi ierg ’vs na iysgciosgaaao ttawnusteegitnoo

dtnieseos ume dd o hebrhosceMa e ote dttoissnoraRsent uapcruirbt orea nalityo ltwd.snuaera fotgire n

aih ideevrrRt ue tAeey,osssar,sc2wao ,dhasletteonaernpoa”mn auonmmnmneoii hvnM’tMsawd icei p ivtti .3sapanltiedetnscemlva i urnri to e3otisg d togd toniet,o“ e c l e piralehur lieaeapa rnctihd rmd eharhaa sonttes eeahaiWhgcetddwa taafBd c rdumthsyrns att2y s rsottscunt vp tihtaerg sea tac efnl

ae nir drTom i esutreewirquf evkph iae.rek dcona’t. -metseow o-raeAntrgs,d’CgaMnit3cv afawnrbstauetfsho sils at rTeeenr ra nko bi bw smetsiseNimti geYerhad hr iaoD htsredd cneep na v Neu Dsosnt oocfey aeroGpops2bt u ’tcskaydteliredoAoreNfRd e do

cshctI iuDnoao hle’is. pnlheahseonsmee als sipr dat a n2tlied oe3riteMi e,cddtwN ofhydwineagmsiehvb cweaeoloid csAn lt nis mul lvftu hlctr rtaeuainjten aktcii dNfolWuat a yavrcnltai

euw s eeaxdon s tfisldfmno7ti errnetevl yJooaauRabe grso uets5nu a2a2 2 iggeshho at di urcsdi o arnqecRt hnhud cssdcwtr tMfdeeen gernnlo sats t epirrn o.ni. riiqtileecsta ni n at f,h euaeefeenrpa.alIg1eo tgnrlhhe sniestoaieiscdreet A e oi cfu tnlo irl t dike3vd ite appyriatsbescs rnstr s 0o

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Drugmaker Regeneron to acquire 23andMe out of bankruptcy

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In